Download 2014 POSTGRADUATE CANCER RESEARCH SYMPOSIUM Monday, 3 NOVEMBER 2014

2014 POSTGRADUATE CANCER RESEARCH SYMPOSIUM
Monday, 3 NOVEMBER 2014
New Law Building, The University of Sydney
PLENARY SESSION
New Law Lecture Theatre 026
Chair: Sarah Frost
9.30
Welcome and introduction
9.40
PLENARY ADDRESS
Professor Peter Lay
ARC Professorial Fellow and Professor of Inorganic Chemistry, The University of Sydney
Q&A
10.00
CONCURRENT SESSIONS
Session 2 – Cell biology
New Law Seminar Room 020
10.10
10.25
10.40
10.55
11.10
11.25
Chair: Indhu Subramanian
P1: DIFFERENCE IN CHROMATIN STRUCTURE BETWEEN ALT
AND TELOMERASE CANCER CELLS
Monica Brygula
Children’s Medical Research Institute
P2: ENDOMETRIAL GLAND SPECIFIC ANDROGEN ACTIONS
REGULATE PTEN INACTIVATION INDUCED UTERINE DISORDERS
Jaesung Peter Choi
ANZAC Research Institute
P3: ROLE OF TGF-β SIGNALLING IN THE CYTOSKELETAL
DYNAMICS OF CYTOTOXIC T CELLS DURING MIGRATION IN THE
TUMOUR MICROENVIRONMENT
Jorge Galeano
Sydney Medical School
P4: THE P38-MK2-HUR PATHWAY POTENTIATES EGFRVIII-IL-1ΒDRIVEN IL-6 SECRETION IN GLIOBLASTOMA CELLS
Fadi Gurgis
School of Medical Science (Pharmacology)
P5: CELLULAR IRON DEPLETION INDUCES THE AMPK MEDIATED
STRESS PATHWAYS IN CANCER CELLS
Sukriti Krishan
Molecular Pathology and Pharmacology Program, Department
of Pathology, Sydney Medical School
Session 3 – Drug development
New Law Seminar Room 022
Chair: Krystal Lester
P6: STUDIES ON SYNTHESIS AND ACTIVITY OF
MONOFUNCTIONAL PALLADIUMS
Md Nur Alam
Discipline of Biomedical Science
P7: ACTIVITY OF MYCOPHENOLIC ACID AND KAEMPFEROL
AGAINST OVARIAN TUMOUR MODELS
Md Sheikh Anwar
Discipline of Biomedical Science
P8: GENERATION OF NEW HISTONE DEACETYLASE INHIBITORS
THROUGH DEVELOPMENTS IN CHEMICAL BIOLOGY
Tomas Richardson-Sanchez
Discipline of Pharmacology
P9: THE EFFECTS OF METALS-BASED DRUGS IN THE
BIOCHEMICAL CHANGES OF LIVE CELLS
Anna Safitri
School of Chemistry
P10: SYNTHESIS AND CHARACTERISATION OF STERICALLY
HINDERED PYRIDINE BASED MULTINUCLEAR PLATINUM
ANTICANCER COMPLEXES AND THEIR CYTOTOXICITY
Michael Apps
Faculty of Pharmacy
MORNING TEA
CONCURRENT SESSIONS
Session 4 – Targeted therapies
New Law Seminar Room 020
Chair: Sarah Frost
11.40
P11: SYNERGISM FROM COMBINATION OF TARGETED THERAPY
AND PHYTOCHEMICALS IN COLORECTAL CANCER
Muhammad Almoyad
Discipline of Biomedical Sciences
11.55
P12: COMBINATIONS OF TARGETED THERAPY AND
PHYTOCHEMICALS AIMED TO PROVIDE AN AFFORDABLE
MEANS TO OVERCOME DRUG RESISTANCE IN OVARIAN
CANCER
Fahad Nasser Al-Onazi
Sydney Medical School
P13: STUDIES ON COMBINATIONS OF TARGETED DRUGS WITH
TUMOUR ACTIVE PLANT COMPOUNDS IN CANCER
Hana Bali
Discipline of Biomedical Science, School of Medical Sciences
12.10
Session 5 – Cancer control, care and quality of life
New Law Seminar Room 022
Chair: Adam Walczak
P17: EVALUATION OF THE FIRST YEAR OF THE SYDNEY
SURVIVORSHIP CLINIC AT CONCORD CANCER CENTRE:
FEASIBILITY, FUNCTION AND CLINICAL PATHWAYS
Jane Turner
Centre for Medical Psychology & Evidence-based Decision-making
P18: NUTRITIONAL RISK FOLLOWING EXTRAPLEURAL
PNEUMONECTOMY FOR MALIGNANT PLEURAL
MESOTHELIOMA
Jason Fowler
Centre for Medical Psychology & Evidence-based Decision-making
P19: MANAGING AND ENHANCING FAMILY INVOLVEMENT IN
CANCER CONSULTATIONS: DEVELOPING A NEW CONCEPTUAL
FRAMEWORK AND CLINICAL STRATEGIES
Rebekah Laidsaar-Powell
Centre for Medical Psychology & Evidence-based Decision-making
PAUSE
12.30
P14: 3D SCAFFOLD FREE LIVER CANCER MODEL FOR
NANOPARTICLE BASED ANTI-CANCER DRUG DELIVERY
Dipesh Khanal
Faculty of Pharmacy
P20: AN INVESTIGATION OF FACTORS THAT AFFECT ADOPTION
AND COMPLIANCE WITH POST-PROSTATECTOMY TREATMENTS
FOR ERECTILE DYSFUNCTION
Patrick Lumbroso
School of Psychology
12.45
1.00
1.15
P15: TARGETED TREATMENT OF LUNG CANCER USING SILKBASED DRUG CARRIERS
Sally Yunsun Kim
Faculty of Pharmacy
P16: THE IMPACT OF AUDIOVISUAL BIOFEEDBACK ON LUNG
TUMOR MOTION CONSISTENCY
Danny Lee
Radiation Physics Laboratory, Sydney Medical School
LUNCH
CONCURRENT SESSIONS
Session 6 – Breast and prostate cancers
New Law Seminar Room 020
Chair: Jasmine Yee
2.00
2.15
2.30
P21: THE IMPACT OF SEIZURES ON COGNITION AND HEALTH
RELATED QUALITY OF LIFE IN PRIMARY BRAIN TUMOUR
Zebunnessa Rahman
Westmead Hospital
P22: CANCER IN FARMERS, NON-FARM RURAL AND URBAN
RESIDENTS IN THE NSW ‘45 AND UP’ STUDY COHORT
Julie Depczynski
Australian Rural Health Research Collaboration
P23: A ROLE FOR ADIPOCYTE LIPOLYSIS IN BREAST CANCER
PROGRESSION
Seher Balaban
Discipline of Physiology, School of Medical Sciences
P24: MICROSCOPIC DIFFUSION PROPERTIES OF BREAST TISSUE
Narina Norddin
Faculty of Health Sciences
P25: DIFFUSION MICROIMAGING OF LYMPH NODES:
PRELIMINARY FINDINGS
Mariaulpa Sahalan
Brain & Mind Research Institute
Session 7 – Treatment and applied cell biology
New Law Seminar Room 022
Chair: Belinda Wright
P29: UNDERSTANDING NANOPARTICLE ENHANCEMENT OF
RADIOTHERAPY
Hilary Byrne
Institute of Medical Physics, School of Physics
P30: DESIGN, EVALUATION AND SYNTHESIS OF NOVEL
ANTICANCER AGENTS
Zechariah Marting
Faculty of Pharmacy
P31: SYNTHESIS AND IMMUNOLOGICAL EVALUATION OF SELFADJUVANTING MUC1 MALP2 CONJUGATE VACCINE
CANDIDATES
David McDonald
Infectious Diseases and Immunology, Faculty of Chemistry
PAUSE
2.50
3.05
P26: VITAMIN D3 (CHOLECALCIFEROL) ACTS AS A NEGATIVE
REGULATOR OF BREAST CANCER CELL MOTILITY AND
INVASIVENESS IN ACTIVATION OF VDR IN THE ABSENCE OF
CLASSICAL VDR SIGNALLING PATHWAY
Md Musharraf Hossain
Faculty of Engineering
P27: ROLE OF RUNX TRANSCRIPTION FACTORS IN PROSTATE
CANCER
Alison Ferguson
Bosch Institute
P32: MULTI-DIMENSIONAL IMMOBILISED METAL AFFINITY
CHROMATOGRAPHY FOR THE ISOLATION OF BACTERIAL
METABOLITES
Jiesi Gu
Discipline of Pharmacology
P33: THE METASTASIS SUPPRESSOR NDRG1 DOWN-REGULATES
THE EXPRESSION OF SNAIL AND SLUG TO PROMOTE ECADHERIN EXPRESSION IN PANCREATIC CANCER
Sharleen Menezes
Sydney Medical School
P34: HONING THE ONCOLYTIC WEAPON: INCREASED
INVASIVENESS OF VACCINIA-INFECTED CELLS
Anjali Gowripalan
School of Molecular Bioscience
3.20
P28: CHANGES IN TISSUE COMPOSITION PREDICT WATER
DIFFUSION COEFFICIENT CHANGES IN PROSTATE CANCER
Aritrick Chatterjee
Medical Radiation Sciences
3.35
AFTERNOON TEA
3.50 –
4.00
AWARDS CEREMONY
New Law Seminar Room 020
Chair: Sarah Frost
3.50
Most outstanding student presenter within each of the following sessions:
4.00
•
•
•
•
•
•
FINISH
Cell biology
Drug development
Targeted therapies
Cancer control, care and quality of life
Breast and prostate cancers
Treatment and applied cell biology